Phase 1 Study of SAR440894 vs Placebo

NCT04441905 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

42

Enrollment

NIH

Sponsor class

Conditions

Chikungunya Virus Infection

Interventions

OTHER: Placebo
BIOLOGICAL: SAR440894

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)